Loftus J C, Plow E F, Frelinger A L, D'Souza S E, Dixon D, Lacy J, Sorge J, Ginsberg M H
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7114-8. doi: 10.1073/pnas.84.20.7114.
Membrane glycoprotein (GP) IIb-IIIa is a component of a platelet adhesive protein receptor. A region of the heavy chain of GPIIb, defined by the monoclonal antibody PMI-1, is involved in adhesion receptor function. We have localized and chemically synthesized this region of GPIIb. A cDNA clone that directs the synthesis of a fusion protein reactive with the PMI-1 antibody was isolated from a phage lambda gt11 expression library constructed with mRNA from an erythroleukemia (HEL) cell line. The deduced amino acid sequence of this clone indicates that it spans the light-heavy chain junction of GPIIb and contains a portion of the carboxyl terminus of the heavy chain and the amino terminus of the light chain. The PMI-1 epitope was found to be contained within a 9-kDa staphylococcal V8 protease fragment of GPIIb, and such a fragment was predicted within the putative heavy-chain sequence. A computerized antigen prediction program identified a single sequence with a high probability of containing a continuous epitope. A synthetic 17-residue peptide containing this sequence binds PMI-1 and inhibits PMI-1 binding to GPIIb-IIIa. The peptide-antibody complex has an approximate Kd of 1.2 microM, which compares to a Kd of 0.95 microM for PMI-1 binding to GPIIb. The region containing the PMI-1 epitope shows no similarity to corresponding regions of two other adhesion receptors, indicating that this portion of GPIIb may function in activities unique to the platelet receptor.
膜糖蛋白(GP)IIb-IIIa是血小板黏附蛋白受体的一个组成部分。由单克隆抗体PMI-1界定的GPIIb重链区域参与黏附受体功能。我们已对GPIIb的这一区域进行了定位并化学合成。从用红白血病(HEL)细胞系的mRNA构建的λ噬菌体gt11表达文库中分离出一个指导合成与PMI-1抗体发生反应的融合蛋白的cDNA克隆。该克隆推导的氨基酸序列表明,它跨越GPIIb的轻链-重链连接区,包含重链羧基末端的一部分和轻链氨基末端。发现PMI-1表位包含在GPIIb的一个9-kDa葡萄球菌V8蛋白酶片段内,并且在推定的重链序列中预测有这样一个片段。一个计算机化的抗原预测程序识别出一个极有可能包含连续表位的单一序列。一个包含该序列的17个残基的合成肽与PMI-1结合并抑制PMI-1与GPIIb-IIIa的结合。该肽-抗体复合物的解离常数(Kd)约为1.2微摩尔,相比之下PMI-1与GPIIb结合的Kd为0.95微摩尔。包含PMI-1表位的区域与另外两种黏附受体的相应区域没有相似性,这表明GPIIb的这一部分可能在血小板受体特有的活性中发挥作用。